{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Falls to 52-Week Low of Rs.1023.2 Amid Market Pressure
Entero Healthcare Solutions has reached a new 52-week low of Rs.1023.2 today, marking a significant decline in its stock price amid a broader market environment where the Sensex continues to trade near its yearly highs. The stock’s recent performance reflects a series of downward movements over the past four days, culminating in a cumulative return of -3.65% during this period.
Entero Healthcare Solutions Stock Falls to 52-Week Low of Rs.1023.2
Entero Healthcare Solutions has reached a new 52-week low of Rs.1023.2, marking a significant decline amid a broader market that remains resilient. The stock has experienced a four-day consecutive decline, reflecting a total return of -3.65% over this period, while the Sensex continues to trade near its 52-week high.
Entero Healthcare Solutions Falls to 52-Week Low of Rs.1023.2 Amid Market Pressure
Entero Healthcare Solutions has reached a new 52-week low of Rs.1023.2, marking a significant decline in its stock price amid a broader market environment where the Sensex continues to trade near its yearly highs. The stock’s recent performance reflects a series of downward movements over the past four days, culminating in a cumulative return of -3.65% during this period.
Entero Healthcare Solutions Falls to 52-Week Low of Rs.1023.2 Amid Market Pressure
Entero Healthcare Solutions has reached a new 52-week low of Rs.1023.2, marking a significant decline in its stock price amid a period of sustained downward movement. The stock has underperformed its sector and broader market indices, reflecting a challenging phase for the company within the retailing industry.
Entero Healthcare Solutions Falls to 52-Week Low of Rs.1038.3 Amid Market Pressure
Entero Healthcare Solutions has reached a new 52-week low of Rs.1038.3, marking a significant price level as the stock continues to trade below all key moving averages amid a broader market environment showing resilience.
Why is Entero Healthcar falling/rising?
As of 26-Nov, Entero Healthcare Solutions Ltd has experienced a modest decline in its share price, trading at ₹1,052.95, down by ₹4.1 or 0.39%. This movement reflects a continuation of a downward trend amid broader market outperformance, raising questions about the underlying factors influencing the stock’s performance.
Entero Healthcare Solutions Faces Bearish Momentum Amid Technical Shifts
Entero Healthcare Solutions, a key player in the retailing sector, has experienced a notable shift in its technical momentum, reflecting a bearish trend across multiple indicators. Recent price movements and technical signals suggest a cautious outlook for the stock amid broader market dynamics.
Is Entero Healthcar technically bullish or bearish?
As of November 17, 2025, the market trend is mildly bearish, with key indicators like Bollinger Bands and moving averages supporting this view, despite some mildly bullish signals from the MACD.
Entero Healthcare Solutions Faces Mixed Technical Trends Amid Market Evaluation Revision
Entero Healthcare Solutions has recently revised its evaluation amid challenging market conditions, with its stock showing a slight increase. Over the past year, the company has experienced a decline, contrasting with broader market gains. Various technical indicators suggest a mixed outlook, warranting continued observation of its performance.
Is Entero Healthcar overvalued or undervalued?
As of November 14, 2025, Entero Healthcare is considered very attractive and undervalued with a PE ratio of 44.13 and a PEG ratio of 0.31, despite a challenging year-to-date return of -20.6%, indicating strong growth potential compared to its peers.
Is Entero Healthcar technically bullish or bearish?
As of November 14, 2025, Entero Healthcare's technical trend has shifted to bearish, supported by bearish MACD, moving averages, and Bollinger Bands, despite a mildly bullish signal from Dow Theory.
Entero Healthcare Faces Bearish Technical Trends Amid Market Challenges
Entero Healthcare Solutions has recently revised its evaluation amid challenging market conditions, with its stock price declining over the past year. The technical indicators suggest a bearish sentiment, while the company's performance contrasts with the broader market, emphasizing the necessity for strategic adjustments in response to current dynamics.
Is Entero Healthcar overvalued or undervalued?
As of November 14, 2025, Entero Healthcare is considered very attractive and undervalued, with a PE ratio of 44.13, an EV to EBITDA of 23.43, and a PEG ratio of 0.31, indicating strong growth potential despite recent stock performance trailing the Sensex.
Is Entero Healthcar technically bullish or bearish?
As of November 14, 2025, Entero Healthcare's technical trend has shifted to a bearish stance, supported by bearish indicators such as MACD, moving averages, and KST, despite some mildly bullish signals in Dow Theory and OBV.
How has been the historical performance of Entero Healthcar?
Entero Healthcar has shown significant growth over the past five years, with net sales increasing from 1,779.74 Cr in March 2021 to 5,095.78 Cr in March 2025, and profit after tax turning positive at 107.43 Cr. The company has improved its operating profit and total assets while achieving a net cash inflow from investing activities in March 2025.
Is Entero Healthcar technically bullish or bearish?
As of November 14, 2025, Entero Healthcare's technical outlook is bearish, driven by bearish MACD, moving averages, and KST, despite some conflicting signals from Dow Theory.
Is Entero Healthcar overvalued or undervalued?
As of November 14, 2025, Entero Healthcare is considered very attractive and undervalued with a PE ratio of 44.13 and a PEG ratio of 0.31, indicating strong growth potential despite a year-to-date return of -20.6% compared to the Sensex's 8.22%.
Entero Healthcare Q2 FY26: Strong Topline Growth Offset by Margin Pressures and Bearish Technical Setup
Entero Healthcare Solutions Ltd., a small-cap pharmaceutical retailer with a market capitalisation of ₹4,870.39 crores, delivered a mixed performance in Q2 FY26, with robust revenue expansion tempered by margin compression and deteriorating technical indicators. The company reported consolidated net profit of ₹31.60 crores for the quarter ended September 2025, marking a sequential increase of 13.67% quarter-on-quarter and a substantial 33.78% year-on-year growth. However, the stock has come under pressure in recent months, trading at ₹1,119.40 as of November 14, 2025, down 2.50% on the day and reflecting a challenging six-month period that has seen the stock decline 23.00% whilst the broader Sensex gained 3.41%.
Is Entero Healthcar overvalued or undervalued?
As of November 13, 2025, Entero Healthcare is considered overvalued with a PE ratio of 48.71 and high valuation metrics compared to peers like TCS and Infosys, despite recent outperformance against the Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
